C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score - Implications for Future Risk Assessment: Results from a Large Cohort Study in Southern Germany

Circulation

Volumn 109, Issue 11, 2004, Pages 1349-1353

  Koenig, Wolfgang ^a   Löwel, Hannelore ^b,c   Baumert, Jens ^b   Meisinger, Christa ^b,c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

Coronary disease; Epidemiology; Inflammation; Prevention; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; DIABETES MELLITUS; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SMOKING; STATISTICAL ANALYSIS; SUDDEN DEATH;

ADULT; AGED; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; GERMANY; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 1642277853     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000120707.98922.E3     Document Type: Article

References (17)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
3. Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation. 2002;105:886-892.
4. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
5. WHO-MONICA-Project Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease). J Clin Epidemiol. 1988;41:105-114.
6. Loewel H, Lewis M, Hoermann A, et al. Case finding, data quality aspects and comparability of myocardial infarction registers: results of a south German register study. J Clin Epidemiol. 1991;44:249-260.
7. Hense HW, Filipiak B, Döring A, et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg region in southern Germany. Results from 1984/1985, 1989/1990, and 1994/1995 surveys. CVD Prevention. 1998;1:318-327.
8. Hutchinson WL, Koenig W, Fröhlich M, et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem. 2000;46:934-938.
9. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
10. Pearson TA, Mensah GA, Alexander WR, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the Am Heart Association. Circulation. 2003;107:499-511.
11. Akaike H. Information theory as a extension of the maximum likelihood principle. In: Pterov BN, Csaki F, eds. Second International Symposium on Information Theory. Budapest, Hungary: Akademiai Kiado; 1973:267-281.
12. Burnham KP, Anderson DR. Model selection and inference: a practical information-theoretic approach. New York, NY: Springer; 1998:43-48.
13. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
14. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-349.
15. Greenland P, Smith SC, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104:1863-1867.
16. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation. 2003;108:161-165.
17. van der Meer IM, de Maat MP, Kiliaan AJ, et al. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med. 2003;163:1323-1328.